1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes.
about
Indicators of glycemic control in patients with gestational diabetes mellitus and pregnant women with diabetes mellitusClinical Implications of Glucose Variability: Chronic Complications of DiabetesAlternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitolCirculating biomarkers of glycemia in diabetes management and implications for personalized medicineMetabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological settingEffect of mulberry leaf extract with enriched 1-deoxynojirimycin content on postprandial glycemic control in subjects with impaired glucose metabolism.Evaluation of serum 1,5 anhydroglucitol levels as a clinical test to differentiate subtypes of diabetesComparison of daily glucose excursion by continuous glucose monitoring between type 2 diabetic patients receiving biphasic insulin aspart 30 or biphasic human insulin 30.Low levels of 1,5-anhydro-D-glucitol are associated with vascular endothelial dysfunction in type 2 diabetes.Serum metabolomic profiling and incident CKD among African AmericansEffects of thyroid hormone on A1C and glycated albumin levels in nondiabetic subjects with overt hypothyroidismLow levels of C-peptide have clinical significance for established Type 1 diabetes.Glycemic variability and oxidative stress: a link between diabetes and cardiovascular disease?Nontraditional markers of glycemia: associations with microvascular conditions.1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions.Amadori albumin in diabetic nephropathyDiet and glycaemia: the markers and their meaning. A report of the Unilever Nutrition Workshop.Utility of different glycemic control metrics for optimizing management of diabetesThe interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoringInsulin initiation: bringing objectivity to choice.Serum 1,5-anhydroglucitol concentrations are a reliable index of glycemic control in type 2 diabetes with mild or moderate renal dysfunction.A pilot study of the efficacy of miglitol and sitagliptin for type 2 diabetes with a continuous glucose monitoring system and incretin-related markersThe roles of glycated albumin as intermediate glycation index and pathogenic protein.Increased 1,5-anhydroglucitol predicts glycemic remission in patients with newly diagnosed type 2 diabetes treated with short-term intensive insulin therapy.Alternative markers of hyperglycemia and risk of diabetes.Association of 1,5-Anhydroglucitol With Cardiovascular Disease and Mortality.Linagliptin increases incretin levels, lowers glucagon, and improves glycemic control in type 2 diabetes mellitus.A study on the association of serum 1,5-anhydroglucitol levels and the hyperglycaemic excursions as measured by continuous glucose monitoring system among people with type 2 diabetes in China.1,5-Anhydroglucitol as a marker of maternal glycaemic control and predictor of neonatal birthweight in pregnancies complicated by type 1 diabetes mellitus.Association of 1,5-anhydroglucitol and 2-h postprandial blood glucose in type 2 diabetic patients.Clinical application of 1,5-anhydroglucitol measurements in patients with hepatocyte nuclear factor-1alpha maturity-onset diabetes of the young.Evaluation of glycemic variability in well-controlled type 2 diabetes mellitus.1,5-Anhydro-D-Glucitol Could Reflect Hypoglycemia Risk in Patients with Type 2 Diabetes Receiving Insulin Therapy.Relationship of glycemic control markers - 1,5 anhydroglucitol, fructosamine, and glycated hemoglobin among Asian Indians with different degrees of glucose intolerance.Low and exacerbated levels of 1,5-anhydroglucitol are associated with cardiovascular events in patients after first-time elective percutaneous coronary intervention.Plasma metabolomic profiles in association with type 2 diabetes risk and prevalence in Chinese adults.A review of glycated albumin as an intermediate glycation index for controlling diabetes.Excretion rates of 1,5-anhydro-D-glucitol, uric acid and microalbuminuria as glycemic control indexes in patients with type 2 diabetes.1,5-Anhydroglucitol in diabetes mellitus.Metabolomics in human type 2 diabetes research.
P2860
Q26799252-8465F3A9-3D2C-4E50-9762-0DCD6BD6AA66Q26801671-9C002A2B-3720-47E7-A6AD-D7C7B8B5F13BQ26801852-A0EB3811-1827-4B7F-8A65-6959044250F9Q27693123-67195FC7-A610-4F62-A2D0-88597A84E63CQ28748492-80B15057-C8B2-42D4-9FF8-F31FD411E293Q33585892-6255157F-9A2E-437D-92EE-505FFED33D5AQ33602114-CC3805FB-AAB0-4685-82FD-DADA49B1F0DAQ33603569-1D55921A-BB8E-40F3-9B8D-736A2A941843Q33784296-400C7073-0C4C-49D2-908E-A603C7C8AE7AQ34008968-22550D80-7EDC-4B37-9550-6541FBD2D5B1Q34351702-1DACB57A-2D2C-497F-B941-B62A1C5FDC36Q34484912-F4358D9A-3724-4A54-88E1-BF685FB6A0DCQ34486820-B4C68D0E-D1F3-46A0-B492-E5EFC544DE3AQ34718472-D221DC50-2E64-4F7F-9C84-72EA2C3145D2Q34726941-8F799A5E-9D29-4920-86BF-E84274393C65Q34878346-37714EAA-9334-4058-9AC9-01A6B930CE59Q34997385-7E18A398-6236-4971-A78E-284ED4837AF2Q35049855-72B266FF-9934-41FF-B7F8-4C1125105560Q35349795-AB3A3139-0B1D-4491-96C0-F807D375E90FQ35414151-C4966004-B0B3-40BD-9B3E-D50EF44A0516Q35688303-34274086-7675-4626-BE62-9FDCAA817C5FQ35838203-88373D83-243C-41ED-98F6-6E1B1F312572Q35911117-2236C9A7-E8D1-4310-AFA0-24047E66218CQ36194286-DC44553D-ECD4-4FB7-A91C-367AE5AC93DAQ36334628-8C12FB91-5467-4E95-9F4A-136ABF1785FFQ36392849-FD0A1A36-D53E-4D18-9EE9-5E3D250BE831Q36428096-2C5B8603-5668-4221-A653-42A60AA6D191Q36434390-A4E12161-48DC-482E-961B-77B880119E26Q36660438-C0905C4D-06A6-4F36-A39D-299339DFCEEBQ36807508-D3085F1E-5A12-41F7-8C3F-02E0168C0127Q36807529-87A1A6ED-4D2E-4CA6-840E-742D615D43DAQ36900001-90C5D7B8-FBB1-4F2B-B4A3-B75E8250C4F7Q37043631-D7E7BA89-9C10-46BB-A69F-8D91C92B3774Q37292095-F0544D3E-1C81-4404-BE5D-E89F3BF6F471Q37326200-DAC329F9-293F-4B17-8198-D26F0BC5B6F9Q37403973-A03E1034-216B-45D2-B702-3D8482CE7A7FQ37404327-E361F907-3888-4311-A9FC-9C8BEEC7F038Q37692359-ECFE3D8A-EEFD-4A88-8C83-5A18AF350822Q38030840-95FAD0A9-19D5-41E2-B1A2-65920E9DDE1BQ38078841-409C6D3C-A5E9-4B50-A778-080AA3EA5A11
P2860
1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
1,5-anhydroglucitol and postpr ...... rolled patients with diabetes.
@ast
1,5-anhydroglucitol and postpr ...... rolled patients with diabetes.
@en
1,5-anhydroglucitol and postpr ...... rolled patients with diabetes.
@nl
type
label
1,5-anhydroglucitol and postpr ...... rolled patients with diabetes.
@ast
1,5-anhydroglucitol and postpr ...... rolled patients with diabetes.
@en
1,5-anhydroglucitol and postpr ...... rolled patients with diabetes.
@nl
prefLabel
1,5-anhydroglucitol and postpr ...... rolled patients with diabetes.
@ast
1,5-anhydroglucitol and postpr ...... rolled patients with diabetes.
@en
1,5-anhydroglucitol and postpr ...... rolled patients with diabetes.
@nl
P2093
P921
P356
P1433
P1476
1,5-anhydroglucitol and postpr ...... rolled patients with diabetes.
@en
P2093
Eric A Button
Joseph Largay
Kathleen M Dungan
Mary M Kelly
Shuhei Kato
Steven Wittlin
P304
P356
10.2337/DC06-1910
P407
P50
P577
2006-06-01T00:00:00Z